Progyny, Inc. (NASDAQ:PGNY) Given Average Recommendation of “Hold” by Brokerages

Progyny, Inc. (NASDAQ:PGNY) has received a consensus recommendation of “Hold” from the thirteen research firms that are presently covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $23.64.

Several research firms have issued reports on PGNY. BTIG Research raised Progyny from a “neutral” rating to a “buy” rating and set a $28.00 price objective on the stock in a report on Monday, March 31st. Canaccord Genuity Group upped their price target on Progyny from $17.00 to $23.00 and gave the company a “hold” rating in a research note on Friday, February 28th. JPMorgan Chase & Co. raised their price target on Progyny from $17.00 to $23.00 and gave the company a “neutral” rating in a report on Tuesday, January 28th. Finally, Bank of America boosted their price objective on Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a report on Tuesday, February 11th.

Progyny Trading Up 0.2 %

Shares of PGNY stock opened at $21.44 on Monday. Progyny has a 1 year low of $13.39 and a 1 year high of $33.84. The firm’s 50 day moving average is $21.94 and its 200-day moving average is $18.88. The firm has a market capitalization of $1.84 billion, a price-to-earnings ratio of 36.97, a PEG ratio of 2.39 and a beta of 1.33.

Institutional Trading of Progyny

Several hedge funds have recently added to or reduced their stakes in the business. Wealth Enhancement Advisory Services LLC bought a new stake in shares of Progyny in the first quarter worth about $354,000. GAMMA Investing LLC grew its position in shares of Progyny by 233.9% in the 1st quarter. GAMMA Investing LLC now owns 5,379 shares of the company’s stock valued at $120,000 after purchasing an additional 3,768 shares during the period. Olstein Capital Management L.P. bought a new stake in Progyny during the 1st quarter worth approximately $469,000. NBC Securities Inc. raised its holdings in Progyny by 97,037.5% during the 1st quarter. NBC Securities Inc. now owns 23,313 shares of the company’s stock worth $520,000 after buying an additional 23,289 shares during the period. Finally, Mackenzie Financial Corp raised its holdings in Progyny by 423.8% during the 4th quarter. Mackenzie Financial Corp now owns 117,387 shares of the company’s stock worth $2,025,000 after buying an additional 94,978 shares during the period. Institutional investors and hedge funds own 94.93% of the company’s stock.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.